PMID- 22467754 OWN - NLM STAT- MEDLINE DCOM- 20130530 LR - 20220409 IS - 1532-2092 (Electronic) IS - 1099-5129 (Linking) VI - 14 IP - 8 DP - 2012 Aug TI - Left ventricular lead position for cardiac resynchronization: a comprehensive cinegraphic, echocardiographic, clinical, and survival analysis. PG - 1139-47 LID - 10.1093/europace/eus045 [doi] AB - AIMS: We sought to determine the clinical and survival outcomes of cardiac resynchronization therapy (CRT) associated with left ventricular (LV) lead location. The lateral left ventricle has been considered the optimal LV lead location for CRT. METHODS AND RESULTS: Left ventricular lead cinegrams taken in 30 degrees right and left anterior oblique views were evaluated in 457 recipients of CRT with a pacemaker or a defibrillator from 1 January 2002 to 31 December 2008 in this retrospective study. Left ventricular lead placement was prioritized at implantation into posterolateral (PL), anterolateral (AL), middle cardiac, and anterointerventricular coronary veins. Using echocardiographic LV 16-segment analysis, we grouped the leads as anterior, AL, PL, and posterior locations. New York Heart Association (NYHA) class and echocardiography were assessed before and after CRT. Clinical and survival outcomes after CRT were compared among the four LV lead locations. Patient baseline demographic characteristics were similar among these four groups. Improvement in NYHA class was significantly greater in the AL (P= 0.04) and PL (P= 0.03) locations than in the anterior location. There was a tendency for greater improvement in LV ejection fraction among the AL (P= 0.11) and PL (P= 0.08) locations than the anterior location. Kaplan-Meier survival estimate at 4 years varied for location: AL, 72%; anterior, 48%; PL, 62%; and posterior, 72% (P= 0.003). CONCLUSION: Cardiac resynchronization therapy recipients are profiting from all lead positions. However, LV lead placed in the AL and PL positions is more preferential for achieving optimal CRT benefit than leads placed in the anterior position. FAU - Dong, Ying-Xue AU - Dong YX AD - Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. FAU - Powell, Brian D AU - Powell BD FAU - Asirvatham, Samuel J AU - Asirvatham SJ FAU - Friedman, Paul A AU - Friedman PA FAU - Rea, Robert F AU - Rea RF FAU - Webster, Tracy L AU - Webster TL FAU - Brooke, Kelly L AU - Brooke KL FAU - Hodge, David O AU - Hodge DO FAU - Wiste, Heather J AU - Wiste HJ FAU - Yang, Yan-Zong AU - Yang YZ FAU - Hayes, David L AU - Hayes DL FAU - Cha, Yong-Mei AU - Cha YM LA - eng PT - Journal Article DEP - 20120330 PL - England TA - Europace JT - Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology JID - 100883649 SB - IM CIN - Europace. 2012 Aug;14(8):1076-8. PMID: 22832575 MH - Aged MH - Cardiac Resynchronization Therapy/*methods/mortality MH - Echocardiography MH - Electrodes, Implanted MH - Female MH - Follow-Up Studies MH - Heart Ventricles MH - Humans MH - Male MH - Retrospective Studies MH - Stroke Volume MH - Survival Analysis EDAT- 2012/04/03 06:00 MHDA- 2013/06/01 06:00 CRDT- 2012/04/03 06:00 PHST- 2012/04/03 06:00 [entrez] PHST- 2012/04/03 06:00 [pubmed] PHST- 2013/06/01 06:00 [medline] AID - eus045 [pii] AID - 10.1093/europace/eus045 [doi] PST - ppublish SO - Europace. 2012 Aug;14(8):1139-47. doi: 10.1093/europace/eus045. Epub 2012 Mar 30.